1. Home
  2. GRFS vs HLNE Comparison

GRFS vs HLNE Comparison

Compare GRFS & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.93

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Hamilton Lane Incorporated

HLNE

Hamilton Lane Incorporated

HOLD

Current Price

$108.00

Market Cap

6.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
HLNE
Founded
1940
1991
Country
Spain
United States
Employees
23800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.7B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
GRFS
HLNE
Price
$8.93
$108.00
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$10.15
$168.33
AVG Volume (30 Days)
446.1K
694.8K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
1.54%
2.03%
EPS Growth
N/A
41.64
EPS
N/A
3.98
Revenue
N/A
$712,963,000.00
Revenue This Year
$5.47
$9.81
Revenue Next Year
$4.92
$19.69
P/E Ratio
$18.67
$26.47
Revenue Growth
N/A
28.73
52 Week Low
$6.19
$98.00
52 Week High
$11.14
$179.19

Technical Indicators

Market Signals
Indicator
GRFS
HLNE
Relative Strength Index (RSI) 42.21 31.75
Support Level $8.66 N/A
Resistance Level $9.11 $157.95
Average True Range (ATR) 0.29 6.58
MACD -0.05 -2.28
Stochastic Oscillator 42.28 26.10

Price Performance

Historical Comparison
GRFS
HLNE

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.

Share on Social Networks: